A higher incidence of smooth endoplasmic reticulum clusters with aromatase inhibitors

Hiroe Saito, Junko Otsuki, Hiromi Takahashi, Rei Hirata, Toshihiro Habara, Nobuyoshi Hayashi

Research output: Contribution to journalArticle

Abstract

Purpose: This study aimed to analyze whether a regimen of aromatase inhibitor (AI) could reduce the occurrence of smooth endoplasmic reticulum clusters (sERCs) in oocytes. Method(s): The AI and the clomiphene citrate (CC) regimens were compared, regarding the sERC (+) rates and the serum estradiol and progesterone levels on the date of hCG administration, and the duration of AI, CC, and hMG administration. Result(s): The occurrence of sERCs in oocytes from patients treated with AI was significantly higher than that in oocytes from those treated with CC. Both the serum estradiol and progesterone levels were found to be significantly higher in sERC (+) than in sERC (-) cycles. With regard to the CC cycles, no significant differences were detected. The duration of AI and hMG administration was longer for sERC (+) than for sERC (-) cycles. Conclusion: As AI did not reduce the occurrence of sERCs, the elevation of estradiol may not be the cause of sERC occurrence but a consequence. Considering the higher levels of progesterone and longer duration of hMG in sERC (+) cycles, the negative effects of premature luteinization, which frequently occur with the AI protocol, should be investigated further.

Original languageEnglish
Pages (from-to)384-389
Number of pages6
JournalReproductive Medicine and Biology
Volume18
Issue number4
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Smooth Endoplasmic Reticulum
Aromatase Inhibitors
Incidence
Clomiphene
Oocytes
Progesterone
Estradiol
Luteinization
Serum

Keywords

  • aromatase inhibitor
  • clomiphene citrate
  • estradiol
  • progesterone
  • smooth endoplasmic reticulum

ASJC Scopus subject areas

  • Reproductive Medicine
  • Cell Biology

Cite this

A higher incidence of smooth endoplasmic reticulum clusters with aromatase inhibitors. / Saito, Hiroe; Otsuki, Junko; Takahashi, Hiromi; Hirata, Rei; Habara, Toshihiro; Hayashi, Nobuyoshi.

In: Reproductive Medicine and Biology, Vol. 18, No. 4, 01.10.2019, p. 384-389.

Research output: Contribution to journalArticle

Saito, Hiroe ; Otsuki, Junko ; Takahashi, Hiromi ; Hirata, Rei ; Habara, Toshihiro ; Hayashi, Nobuyoshi. / A higher incidence of smooth endoplasmic reticulum clusters with aromatase inhibitors. In: Reproductive Medicine and Biology. 2019 ; Vol. 18, No. 4. pp. 384-389.
@article{b8e636ee463b4fdf94d9b7b9d1884efd,
title = "A higher incidence of smooth endoplasmic reticulum clusters with aromatase inhibitors",
abstract = "Purpose: This study aimed to analyze whether a regimen of aromatase inhibitor (AI) could reduce the occurrence of smooth endoplasmic reticulum clusters (sERCs) in oocytes. Method(s): The AI and the clomiphene citrate (CC) regimens were compared, regarding the sERC (+) rates and the serum estradiol and progesterone levels on the date of hCG administration, and the duration of AI, CC, and hMG administration. Result(s): The occurrence of sERCs in oocytes from patients treated with AI was significantly higher than that in oocytes from those treated with CC. Both the serum estradiol and progesterone levels were found to be significantly higher in sERC (+) than in sERC (-) cycles. With regard to the CC cycles, no significant differences were detected. The duration of AI and hMG administration was longer for sERC (+) than for sERC (-) cycles. Conclusion: As AI did not reduce the occurrence of sERCs, the elevation of estradiol may not be the cause of sERC occurrence but a consequence. Considering the higher levels of progesterone and longer duration of hMG in sERC (+) cycles, the negative effects of premature luteinization, which frequently occur with the AI protocol, should be investigated further.",
keywords = "aromatase inhibitor, clomiphene citrate, estradiol, progesterone, smooth endoplasmic reticulum",
author = "Hiroe Saito and Junko Otsuki and Hiromi Takahashi and Rei Hirata and Toshihiro Habara and Nobuyoshi Hayashi",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/rmb2.12296",
language = "English",
volume = "18",
pages = "384--389",
journal = "Reproductive Medicine and Biology",
issn = "1445-5781",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - A higher incidence of smooth endoplasmic reticulum clusters with aromatase inhibitors

AU - Saito, Hiroe

AU - Otsuki, Junko

AU - Takahashi, Hiromi

AU - Hirata, Rei

AU - Habara, Toshihiro

AU - Hayashi, Nobuyoshi

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Purpose: This study aimed to analyze whether a regimen of aromatase inhibitor (AI) could reduce the occurrence of smooth endoplasmic reticulum clusters (sERCs) in oocytes. Method(s): The AI and the clomiphene citrate (CC) regimens were compared, regarding the sERC (+) rates and the serum estradiol and progesterone levels on the date of hCG administration, and the duration of AI, CC, and hMG administration. Result(s): The occurrence of sERCs in oocytes from patients treated with AI was significantly higher than that in oocytes from those treated with CC. Both the serum estradiol and progesterone levels were found to be significantly higher in sERC (+) than in sERC (-) cycles. With regard to the CC cycles, no significant differences were detected. The duration of AI and hMG administration was longer for sERC (+) than for sERC (-) cycles. Conclusion: As AI did not reduce the occurrence of sERCs, the elevation of estradiol may not be the cause of sERC occurrence but a consequence. Considering the higher levels of progesterone and longer duration of hMG in sERC (+) cycles, the negative effects of premature luteinization, which frequently occur with the AI protocol, should be investigated further.

AB - Purpose: This study aimed to analyze whether a regimen of aromatase inhibitor (AI) could reduce the occurrence of smooth endoplasmic reticulum clusters (sERCs) in oocytes. Method(s): The AI and the clomiphene citrate (CC) regimens were compared, regarding the sERC (+) rates and the serum estradiol and progesterone levels on the date of hCG administration, and the duration of AI, CC, and hMG administration. Result(s): The occurrence of sERCs in oocytes from patients treated with AI was significantly higher than that in oocytes from those treated with CC. Both the serum estradiol and progesterone levels were found to be significantly higher in sERC (+) than in sERC (-) cycles. With regard to the CC cycles, no significant differences were detected. The duration of AI and hMG administration was longer for sERC (+) than for sERC (-) cycles. Conclusion: As AI did not reduce the occurrence of sERCs, the elevation of estradiol may not be the cause of sERC occurrence but a consequence. Considering the higher levels of progesterone and longer duration of hMG in sERC (+) cycles, the negative effects of premature luteinization, which frequently occur with the AI protocol, should be investigated further.

KW - aromatase inhibitor

KW - clomiphene citrate

KW - estradiol

KW - progesterone

KW - smooth endoplasmic reticulum

UR - http://www.scopus.com/inward/record.url?scp=85074199152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074199152&partnerID=8YFLogxK

U2 - 10.1002/rmb2.12296

DO - 10.1002/rmb2.12296

M3 - Article

AN - SCOPUS:85074199152

VL - 18

SP - 384

EP - 389

JO - Reproductive Medicine and Biology

JF - Reproductive Medicine and Biology

SN - 1445-5781

IS - 4

ER -